Quest Diagnostics Study Finds 29.5% of Lyme-Seropositive Patients Show Antibodies to Other Tick-Borne Pathogens

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

E-Home Household Service Holdings Ltd: Appoints Xiaojing Wu as Co-Chief Executive Officer and Director

E-Home Household Service Names Xiaojing Wu Co-CEO, Adds Her to Board

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Nasdaq Jumps 400 Points; US Weekly Jobless Claims Fall

Aethlon Medical Announces Merger with North Immunology

M&A News: Aethlon Medical Stock (AEMD) Rockets 400% After North Immunology Deal to Fight Eczema

U.S. Stocks on the MOVE-Generac, Jefferies, Aethlon Medical

Aethlon Medical, North Immunology enter all-stock transaction

Aethlon Medical Shares Jump 87.4% to $2.68 Premarket After Co Enters Merger Agreement with North Immunology

Aethlon Medical Agrees All-Stock Merger with North Immunology

Aethlon Medical: Pre-Merger Aethlon Stockholders to Own About 4.75%, North Immunology Stockholders to Own About 95.25% of Combined Co

Aethlon Medical - Enters Definitive All-Stock Merger Agreement with North Immunology

Aethlon Medical - Combined Company Expected to Have Pro Forma Equity Value of $346.50 Mln

Aethlon Medical Inc - Pre-Merger North Immunology Stockholders Expected to Own Approximately 95.25% of Combined Company

Aethlon Medical - $180 Mln Private Placement Expected to Fund Operations into Second Half of 2028

Aethlon Medical & North Immunology Announce Merger to Advance Novel Il-13 X Il-18 Bispecific Antibody for Atopic Dermatitis

Aethlon Medical - Stockholders to Receive Contingent Value Right for Each Share Held

Aethlon Medical - Combined Entity to Operate as North Immunology, and Trade Under Ticker Nrtx